ACPE Universal Program Number: 207-000-08-032-H04-P
Release Date: February 29, 2008
Expiration Date: February 28, 2011
Statement of Need
In the past, Medicare Advantage plans have been viewed as a potential threat to pharmacy providers, especially in the presence of exclusive networks. There is no denying that the market is moving toward MA plans, and the challenge for community pharmacists is to find a place in the equation. A real opportunity exists in the MA environment for pharmacists looking to partner with managed care plans for whom pharmacist-provided MTM is valued, generic utilization is encouraged, and incentives are aligned. Plans are seeking pharmacist partners to utilize their unique skills to keep patients healthy. This program will examine MA plans and discuss potential outreach opportunities for pharmacists to work with plans and improve the health outcomes of Medicare beneficiaries.
Instructions for Participation
To receive a certificate of completion that indicates your eligibility for continuing education credit, you must:
- Review the content of the activity.
- Successfully complete the post-test (9 out of 12 correct answers or higher).
- You will have two (2) opportunities to successfully complete the activity.
Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.
Fee
There is no fee for this activity.
Accreditation
Pharmacists
NCPA
is accredited by the Accreditation Council for Pharmacy Education
as a provider of continuing pharmacy education. This program will
provide 1.0 contact hours (.1 CEUs) of continuing pharmacy education
credit under the number 207-000-08-032-H04-P.
Faculty
Bob Donnelly (click on faculty name to view biography)
Vice President of Government Programs
MemberHealth, Inc.
Solon, Ohio
Mike Bukach, RPh (click on faculty name to view biography)
Vice President of Pharmacy Operations
MemberHealth, Inc.
Solon, Ohio
Disclosure Declaration
It is the policy of the National Community Pharmacists Association (NCPA) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.
The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.
Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
Commercial Support Statement
Commercial Support Provided by Community CCRx.
Software Requirements